| |
| |
|
| Insider
Information: |
Baysal Ozer |
| Relationship: |
Chief Commercial Officer |
| City: |
Lexington |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
58,790 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$26,073 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
58,790 |
|
|
| Total
Value |
$26,073 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Antigenics Inc |
AGEN |
Chief Commercial Officer |
2017-12-12 |
58,790 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
14 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AGEN |
Antigenics Inc |
Chief Commercial Officer |
• – – |
2017-12-12 |
4 |
S |
$3.46 |
$12,846 |
D/D |
(3,712) |
58,790 |
0 |
- |
|
| AGEN |
Antigenics Inc |
Chief Commercial Officer |
• – – |
2017-10-09 |
4 |
A |
$3.59 |
$46,957 |
D/D |
13,080 |
62,502 |
0 |
- |
|
| AGEN |
Antigenics Inc |
Chief Business Officer |
• – – |
2017-04-19 |
4 |
D |
$3.39 |
$11,997 |
D/D |
(3,539) |
49,422 |
0 |
- |
|
| AGEN |
Antigenics Inc |
Chief Business Officer |
• – – |
2017-04-19 |
4 |
A |
$3.39 |
$44,334 |
D/D |
13,078 |
52,961 |
0 |
- |
|
| AGEN |
Antigenics Inc |
Chief Business Officer |
• – – |
2017-01-03 |
4 |
A |
$4.16 |
$26,000 |
D/D |
6,250 |
39,883 |
0 |
- |
|
| AGEN |
Antigenics Inc |
Chief Business Officer |
• – – |
2016-05-05 |
4 |
B |
$3.10 |
$6,975 |
D/D |
2,250 |
33,538 |
2.74 |
- |
|
| AGEN |
Antigenics Inc |
Chief Business Officer |
• – – |
2016-04-26 |
4/A |
D |
$4.15 |
$14,712 |
D/D |
(3,545) |
33,633 |
0 |
- |
|
| AGEN |
Antigenics Inc |
Chief Business Officer |
• – – |
2016-04-26 |
4/A |
A |
$4.15 |
$54,274 |
D/D |
13,078 |
37,178 |
0 |
- |
|
| AGEN |
Antigenics Inc |
Chief Business Officer |
• – – |
2016-04-26 |
4 |
|
$4.15 |
$14,562 |
D/D |
3,509 |
9,438 |
0 |
- |
|
| AGEN |
Antigenics Inc |
Chief Business Officer |
• – – |
2016-04-26 |
4 |
A |
$4.15 |
$53,730 |
D/D |
12,947 |
12,947 |
0 |
- |
|
| AGEN |
Antigenics Inc |
Chief Business Officer |
• – – |
2016-01-04 |
4 |
A |
$4.46 |
$27,875 |
D/D |
6,250 |
21,850 |
0 |
- |
|
| AGEN |
Antigenics Inc |
CBO |
• – – |
2015-01-02 |
4 |
A |
$3.98 |
$24,875 |
D/D |
6,250 |
15,600 |
0 |
- |
|
| AGEN |
Antigenics Inc |
Chief Business Officer |
• – – |
2014-01-02 |
4 |
A |
$2.78 |
$17,375 |
D/D |
6,250 |
9,350 |
0 |
- |
|
| AGEN |
Antigenics Inc |
Chief Business OfficerOfficer |
• – – |
2013-06-13 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
3,100 |
|
- |
|
14 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
